EPGNY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 Sep 2022 @ 20:34):

Stats
Tagesvolumen	212.00
Durchschnittsvolumen	9.00
Marktkapitalisierung	0.00
Last Dividend	$0.0297 ( 2021-09-16 )
Next Dividend	$0 ( N/A )
P/E	-1.604
ATR14	$0 (0.00%)

Epigenomics AG Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Epigenomics AG Finanzdaten

Annual	2021
Umsatz:	$6.20M
Bruttogewinn:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2021
Umsatz:	$6.20M
Bruttogewinn:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2020
Umsatz:	$842 000
Bruttogewinn:	$697 000 (82.78 %)
EPS:	$-2.48

FY	2019
Umsatz:	$1.13M
Bruttogewinn:	$872 000 (77.51 %)
EPS:	$-4.48

Financial Reports:

No articles found.

Epigenomics AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Epigenomics AG Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.458 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.833	2018-10-31
Last Dividend	$0.0297	2021-09-16
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$2.72	--
Avg. Dividend % Per Year	0.00%	--
Score	0.55	--
Div. Sustainability Score	0.458
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-09-23)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.55

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RKAGY	Ex Dividend Junior	2023-06-08	Annually	0.00%
EPOKY	Ex Dividend Knight	2023-10-23	Semi-Annually	0.00%
WTBFB	Ex Dividend Junior	2023-09-07	Quarterly	0.00%
LLESY	Ex Dividend Junior	2023-08-24	Semi-Annually	0.00%
CCHGY	Ex Dividend Knight	2023-05-25	Annually	0.00%
SMAL	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
FSUGY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
NABZY	Ex Dividend Junior	2023-05-12	Semi-Annually	0.00%
CNLHP	Ex Dividend Junior	2023-08-09	Quarterly	0.00%
TGOPY	Ex Dividend Knight	2023-06-22	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.391	1.500	-7.83	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0984	1.200	-3.28	-3.94	[0 - 0.3]
returnOnEquityTTM	-0.187	1.500	-3.19	-4.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	11.06	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	10.72	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	10.72	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0187	-1.500	9.69	-10.00	[0 - 0.6]
interestCoverageTTM	-45.35	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
freeCashFlowPerShareTTM	-0.467	2.00	-0.233	-0.467	[0 - 20]
debtEquityRatioTTM	0.0208	-1.500	9.92	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.978	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.380	1.000	-9.60	-9.60	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-9.03	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.252	0.800	-1.657	-1.325	[0.5 - 2]
Total Score				0.458

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-8.20	1.000	-0.929	0	[1 - 100]
returnOnEquityTTM	-0.187	2.50	-2.05	-4.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.467	2.00	-0.156	-0.467	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.463	1.500	-6.42	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.669	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.63

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.